Oncology Drive Boosts London’s Biggest Pharma Firms Astra and GSK
Astra and GSK boosted by oncology; Aston Martin’s still stuck in first gear
This article is for subscribers only.
Morning, I’m Louise Moon from Bloomberg UK’s breaking news team, bringing you up to speed on today’s top business stories.
Strong sales of cancer medicines are proving a boon to the two largest London-listed drugmakers: AstraZeneca and GSK.